Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey

Ann Intern Med. 2019 Oct 15;171(8):596-598. doi: 10.7326/M19-0953. Epub 2019 Jul 23.

Authors

Colin W O'Brien¹, Stephen P Juraschek², Christina C Wee²

Affiliations

¹ Harvard Medical School, Boston, Massachusetts (C.W.O.).
² Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (S.P.J., C.C.W.).

No abstract available

MeSH terms

Adult
Age Factors
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Female
Health Surveys
Humans
Male
Middle Aged
Prevalence
Primary Prevention / statistics & numerical data*
United States

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin

Grants and funding